Autoantibodies in normals - The value of predicting rheumatoid arthritis

Arthritis Research and Therapy

Volumn 6, Issue 6, 2004, Pages 282-284

  Dörner, Thomas ^a   Hansen, Arne ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DEIMINASE; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; AUTOIMMUNITY; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME ACTIVITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNE RESPONSE; PREDICTION; PROGNOSIS; PROTEIN METABOLISM; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE VALUES; RHEUMATOID FACTOR; RISK FACTORS;

EID: 8544247220     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1456     Document Type: Review

References (27)

1. Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, t' Hart BA, Breedveld FC, Tak PP: Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41: 481-1488.
2. Silman AJ, Hennessy E, Ollier B: Incidence of rheumatoid arthritis in a genetically predisposed population. Br J Rheumatol 1992, 31:365-368.
3. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T: Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991, 18:1282-1284.
4. Kurki P, Aho K, Palosuo T, Heliövaara M: Immunopathology of rheumatoid arthritis: antikeratin antibodies precede the clinical disease. Arthritis Rheum 1992, 35:914-917.
5. Halldorsdottir HD, Jonsson T, Thorsteinsson J, Valdimarsson H: A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann Rheum Dis 2000, 59:149-151.
6. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH: The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988, 31: 239-1244.
7. Walker DJ, Pound JD, Griffiths ID, Powell RJ: Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis. Ann Rheum Dis 1986, 45:684-690.
8. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000, 2:236-243.
9. Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
10. Jansen LMA, van der Horst Bruinsma IE, van Schaardenburg D, van de Stadt RJ, de Koning MHMT, Dijkmans BAC: Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002, 29:2074-2076.
11. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
12. McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA: The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004, 50: 226-1232.
13. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB: Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001, 54:211-219.
14. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vanden-broucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
15. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW: Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004, 50:709-715.
16. Aho K, Koskela P, Makitalo R, Heliovaara M, Palosuo T: Anti-nuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 1992, 19:1377-1379.
17. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994, 343:1383-1385.
18. Eisenbarth GS, Gottlieb PA: Autoimmune polyendocrine syndromes. N Engl J Med 2004, 350:2068-2079.
19. Mowat AM: Coeliac disease - a meeting point for genetics, immunology, and protein chemistry. Lancet 2003, 361: 290-1292.
20. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens IA-2 and GAD in type I (insulin dependent) diabetes. Diabetologia 1999, 42:3-14.
21. Dömer T, Egerer K, Feist E, Burmester GR: Rheumatoid factor revisited. Curr Opin Rheumatol 2004, 16:246-53.
22. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003, 171:538-541.
23. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: Functional haplotypes of PAD14, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34: 395-402.
24. Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, Worthington J: A functional haplotype of the PAD14 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004, 50: 117-1121.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
26. Huizinga TWJ, Machold KP, Breedveld FC, Lipsky PE, Smolen JS: Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum 2002, 46: 155-1159.
27. El-Gabalawy HS, Duray P, Goldbach-Mansky R: Evaluating patients with arthritis of recent onset: studies in pathogenesis and prognosis. JAMA 2000, 284:2368-2373.